The SARS-CoV-2 (COVID-19) Anti-Spike IgG Antibody Plus test is a diagnostic test that detects the presence of IgG antibodies against the spike protein of the SARS-CoV-2 virus in a person's blood sample. The test works by using a chemiluminescent immunoassay to identify the specific antibodies produced by the immune system in response to the virus. The test is highly specific for the spike protein, which is responsible for the virus's ability to enter and infect human cells. The results of the test can help determine if a person has been infected with the virus or has developed immunity through vaccination. This test can be used to track the spread of the virus, monitor the effectiveness of vaccination campaigns, and identify individuals who may have had mild or asymptomatic cases of COVID-19.

The SARS-CoV-2 (COVID-19) Anti-Spike IgG Antibody Plus test is taken to detect the presence of IgG antibodies against the spike protein of the virus in a person's blood sample. The test is used to determine if a person has previously been infected with the virus or has developed immunity through vaccination. This information can help health officials better understand the spread of the virus in a population and guide public health policies.

Additionally, the test can help identify individuals who may have had mild or asymptomatic cases of COVID-19, providing insight into the true prevalence of the disease. Finally, the test can help monitor the effectiveness of vaccination campaigns and determine if booster shots are necessary to maintain immunity.

3 mL (1 mL min.) Serum from 1 SST. Ship refrigerated or frozen. Duly filled Covid-19 Antibody Test Form (Form 45) is mandatory.

CLIA, EIA

Sample Mon Thu by 4 pm; Report Next day

*Sars-CoV-2 Anti Spike IgG Antibody Quantitative *Sars-CoV-2 Antibody Neutralising

Duly filled Covid-19 Antibody Test Form (Form 45) is mandatory.